Regencell Bioscience Holdings Limited
RGC
株式のランク
#3446
Regencell Bioscience Holdings Limited is a biotechnology firm specializing in... Regencell Bioscience Holdings Limited is a biotechnology firm specializing in Traditional Chinese Medicine (TCM). Its core activities revolve around the research, development, and market introduction of TCM solutions specifically designed to address neurocognitive disorders and related degeneration. The company places a particular emphasis on conditions such as attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). Established in 2014, Regencell Bioscience maintains its primary office in Causeway Bay, Hong Kong.
株価
$10.10
時価総額
$5.01B
変化（1日）
5.32%
変化（1年）
-41.99%
国
HK
取引 Regencell Bioscience Holdings Limited (RGC)
カテゴリー
Healthcare
Regencell Bioscience Holdings Limited（RGC）のEPS
June 2026 時点のEPS TTM: $-0.02
Regencell Bioscience Holdings Limitedの最新の財務報告と株価によると、同社の現在のEPS（TTM）は$-0.02です。2024年末には、EPSは$-0.01で、2023年のEPS$-0.01と同等でした。
Regencell Bioscience Holdings LimitedのEPS履歴（2019から2026まで）
各年末時点のEPS
| 年 | EPS | 変化 |
|---|---|---|
| 2026 (TTM) | $-0.02 | 136.00% |
| 2025 | $-0.01 | -17.24% |
| 2024 | $-0.01 | -26.89% |
| 2023 | $-0.01 | -20.67% |
| 2022 | $-0.02 | 435.71% |
| 2021 | 0.00 | 64.71% |
| 2020 | 0.00 | 112.50% |
| 2019 | 0.00 | 0.00% |
同様の企業または競合他社のEPS
| 企業 | EPS | EPSの差 | 国 |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | -2,457.20% |
IN
|
